Friday, February 27, 2009 1:28:42 PM
Another thing about IDIX - an investment here pins its future on the HiV market. In reality though, HiV is nowhere the medical problem it used to be, and is largely controllable. Plus the market is hugely competitive, and is dominated by drug cocktails. This phase one candidate is one of the longest shots ever. And apart from that, what else is in the pipeline ? Not much.
Sell.
"....on the biotech battle-field, you need some élan...."
FEATURED Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
